Wojtek Steffen
Wojtek Steffen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Alfred M. Engel
Centralized & Point of Care Solutions, Roche Diagnostics GmbH, Nonnenwald 2, Penzberg, 82377, Germany
1 shared publication - Andreas Leinenbach
Department of Early Development and Reagent Design, Roche Diagnostics GmbH, Nonnenwaldstr. 2, 82377 Penzberg, Germany
1 shared publication - Dominic Knoblauch
Department of Early Development and Reagent Design, Roche Diagnostics GmbH, Nonnenwaldstr. 2, 82377 Penzberg, Germany
1 shared publication Frank Bergmann
From Roche Diagnostics GmbH, CPS, Nonnenwald 2, 82377 Penzberg, Germany
1 shared publication- Franziska Popp
Department of Early Development and Reagent Design, Roche Diagnostics GmbH, Nonnenwaldstr. 2, 82377 Penzberg, Germany
1 shared publication Fu Chong Ko
From Roche Diagnostics GmbH, CPS, Nonnenwald 2, 82377 Penzberg, Germany
1 shared publication
Latest Publications
- Open Access
- 5 February 2021
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 31 (7) , 762-771
Glycosylation of recombinant rabbit immunoglobulins influences protease susceptibility as shown by comprehensive mass spectrometric glycan analysis
Recombinant immunoglobulins (rIgGs) have become increasingly important as therapeutic agents and diagnostic tools in recent years. Genetic engineering allows the introduction of non-natural features such as the Sortase motif for site-directed labeling. In this study, the enzyme Sortase A (SrtA) was used for the proteolytic cleavage of rIgGs to produce their biotinylated Fab fragments by locating the cleavage site close to the hinge region. However, SrtA cleavage of engineered rabbit IgGs (rRb-IgGs) derived from human embryonic kidney (HEK) 293 cells showed significantly lower yields compared with their mouse counterparts. Nonrecombinant Rb-IgGs have N- and O-glycans, and the presence of O-glycans close to the hinge region of the rRb-IgGs might affect the susceptibility of these antibodies to SrtA cleavage. In addition, the glycosylation pattern of rIgGs differs depending on the host cell used for expression. Therefore, we analyzed the N- and O-glycans of various rRb-IgGs expressed in HEK293 cells, detecting and quantifying 13 different N-glycan and 3 different O-glycan structures. The distribution of the different detected glycoforms in our rRb-IgG N-glycan analysis is in agreement with previous studies on recombinant human IgG N-glycans, confirming the hypothesis that the host cell defines the glycosylation of the recombinant produced IgGs. O-glycosylation could be mapped onto the threonine residue within the hinge region sequence XPTCPPPX, as already described previously for nonrecombinant Rb-IgGs. Substitution of this threonine allowed an almost complete Fab fragment cleavage. Therefore, we could confirm the hypothesis that the O-glycans affect the SrtA activity, probably due to steric hindrance.
- 5 February 2021
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 31 (7) , 762-771
Open AccessGlycosylation of recombinant rabbit immunoglobulins influences protease susceptibility as shown by comprehensive mass spectrometric glycan analysis
Recombinant immunoglobulins (rIgGs) have become increasingly important as therapeutic agents and diagnostic tools in recent years. Genetic engineering allows the introduction of non-natural features such as the Sortase motif for site-directed labeling. In this study, the enzyme Sortase A (SrtA) was used for the proteolytic cleavage of rIgGs to produce their biotinylated Fab fragments by locating the cleavage site close to the hinge region. However, SrtA cleavage of engineered rabbit IgGs (rRb-IgGs) derived from human embryonic kidney (HEK) 293 cells showed significantly lower yields compared with their mouse counterparts. Nonrecombinant Rb-IgGs have N- and O-glycans, and the presence of O-glycans close to the hinge region of the rRb-IgGs might affect the susceptibility of these antibodies to SrtA cleavage. In addition, the glycosylation pattern of rIgGs differs depending on the host cell used for expression. Therefore, we analyzed the N- and O-glycans of various rRb-IgGs expressed in HEK293 cells, detecting and quantifying 13 different N-glycan and 3 different O-glycan structures. The distribution of the different detected glycoforms in our rRb-IgG N-glycan analysis is in agreement with previous studies on recombinant human IgG N-glycans, confirming the hypothesis that the host cell defines the glycosylation of the recombinant produced IgGs. O-glycosylation could be mapped onto the threonine residue within the hinge region sequence XPTCPPPX, as already described previously for nonrecombinant Rb-IgGs. Substitution of this threonine allowed an almost complete Fab fragment cleavage. Therefore, we could confirm the hypothesis that the O-glycans affect the SrtA activity, probably due to steric hindrance.
- Open Access
- 1 September 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (38) , 15622-15635
Discovery of a microbial transglutaminase enabling highly site-specific labeling of proteins
- 1 September 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (38) , 15622-15635
Open AccessDiscovery of a microbial transglutaminase enabling highly site-specific labeling of proteins